GoHealth Inc. (NASDAQ:GOCO) does about 3.51M shares in volume on a normal day but saw 1533755 shares change hands in Friday trading. The company now has a market cap of 5.34B USD and an enterprise value of about $6.14B. Its current market price is $15.97, marking a decrease of -6.22% compared to the previous close of $17.03. The 52 week high reached by this stock is $26.25 whilst the lowest price level in 52 weeks is $15.14. The script in recent trading has seen the stock touch a high of $17.61 and a low of $15.86.
GoHealth Inc. (GOCO) has a 20-day trading average at $17.59 and the current price is -39.16% off the 52-week high compared with 5.48% distance from its 52-week low. If we look at the stock’s price movements over the week, volatility stands at 9.05%, which decreases to 7.31% over 1 month.
The consensus objective for the share price is $23.44, suggesting that the stock has a potential upside of 31.87% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on August 11, 2020 when William Blair initiated the stock to “Outperform” and issued a price target of. Morgan Stanley initiated its price target at $17.
The current price level is -10.18%, -13.93%, and -13.93% away from its SMA20, SMA50, and SMA200 respectively, with the GOCO price moving above the 50-day SMA on August 21. GoHealth Inc. (GOCO) stock is down -5.05% over the week and -24.06% over the past month. Its price is -17.93% year-to-date.
The stock last released its quarterly earnings report for quarter ended 6/29/2020, with the company’s earnings per share (EPS) of -$0.07 below consensus estimates by -$0.03. Expected sales for next quarter are $451.91 million, which analysts say will come at $866.13 million for the current fiscal year and next year at $1.19 billion. In addition, estimates put the company’s current quarterly revenue at an average of $176.52 million.
Its 12-month price target is $23.00. To reach the target analysts have set, the stock logically needs to grow 31.87 percent from here. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $18.00, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $27.00.
The company has a return on investment of -5.40%. The forward price to earnings ratio is 19.01. Price to sales ratio is 8.04.